nodes	percent_of_prediction	percent_of_DWPC	metapath
Bisoprolol—CYP2D6—Alzheimer's disease	0.339	1	CbGaD
Bisoprolol—CYP2D6—Rivastigmine—Alzheimer's disease	0.108	0.264	CbGbCtD
Bisoprolol—CYP2D6—Donepezil—Alzheimer's disease	0.0867	0.211	CbGbCtD
Bisoprolol—CYP3A4—Rivastigmine—Alzheimer's disease	0.069	0.168	CbGbCtD
Bisoprolol—CYP2D6—Galantamine—Alzheimer's disease	0.0559	0.136	CbGbCtD
Bisoprolol—CYP3A4—Donepezil—Alzheimer's disease	0.0551	0.134	CbGbCtD
Bisoprolol—CYP3A4—Galantamine—Alzheimer's disease	0.0355	0.0865	CbGbCtD
Bisoprolol—Chlorphenesin—BCHE—Alzheimer's disease	0.00068	0.221	CrCbGaD
Bisoprolol—Betaxolol—CYP2D6—Alzheimer's disease	0.000376	0.122	CrCbGaD
Bisoprolol—Acebutolol—CYP2D6—Alzheimer's disease	0.000344	0.112	CrCbGaD
Bisoprolol—Depression—Rivastigmine—Alzheimer's disease	0.000342	0.00148	CcSEcCtD
Bisoprolol—Oxprenolol—CYP2D6—Alzheimer's disease	0.000342	0.111	CrCbGaD
Bisoprolol—Oedema peripheral—Donepezil—Alzheimer's disease	0.000341	0.00148	CcSEcCtD
Bisoprolol—Conjunctivitis—Memantine—Alzheimer's disease	0.000341	0.00148	CcSEcCtD
Bisoprolol—Urinary tract infection—Memantine—Alzheimer's disease	0.000341	0.00148	CcSEcCtD
Bisoprolol—Cough—Galantamine—Alzheimer's disease	0.00034	0.00147	CcSEcCtD
Bisoprolol—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000338	0.00147	CcSEcCtD
Bisoprolol—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000336	0.00146	CcSEcCtD
Bisoprolol—Visual impairment—Donepezil—Alzheimer's disease	0.000334	0.00145	CcSEcCtD
Bisoprolol—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000333	0.00145	CcSEcCtD
Bisoprolol—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000333	0.00145	CcSEcCtD
Bisoprolol—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000331	0.00144	CcSEcCtD
Bisoprolol—Arthralgia—Galantamine—Alzheimer's disease	0.000331	0.00144	CcSEcCtD
Bisoprolol—Myalgia—Galantamine—Alzheimer's disease	0.000331	0.00144	CcSEcCtD
Bisoprolol—Chest pain—Galantamine—Alzheimer's disease	0.000331	0.00144	CcSEcCtD
Bisoprolol—Anxiety—Galantamine—Alzheimer's disease	0.00033	0.00143	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000329	0.00143	CcSEcCtD
Bisoprolol—Sinusitis—Memantine—Alzheimer's disease	0.000329	0.00143	CcSEcCtD
Bisoprolol—Sweating—Rivastigmine—Alzheimer's disease	0.000329	0.00143	CcSEcCtD
Bisoprolol—Discomfort—Galantamine—Alzheimer's disease	0.000327	0.00142	CcSEcCtD
Bisoprolol—Agranulocytosis—Memantine—Alzheimer's disease	0.000327	0.00142	CcSEcCtD
Bisoprolol—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.000324	0.00141	CcSEcCtD
Bisoprolol—Dry mouth—Galantamine—Alzheimer's disease	0.000324	0.00141	CcSEcCtD
Bisoprolol—Tinnitus—Donepezil—Alzheimer's disease	0.000323	0.0014	CcSEcCtD
Bisoprolol—Sinusitis—Rivastigmine—Alzheimer's disease	0.000322	0.0014	CcSEcCtD
Bisoprolol—Confusional state—Galantamine—Alzheimer's disease	0.00032	0.00139	CcSEcCtD
Bisoprolol—Bradycardia—Memantine—Alzheimer's disease	0.00032	0.00139	CcSEcCtD
Bisoprolol—Rhinitis—Memantine—Alzheimer's disease	0.000315	0.00137	CcSEcCtD
Bisoprolol—Hepatitis—Memantine—Alzheimer's disease	0.000315	0.00137	CcSEcCtD
Bisoprolol—Bradycardia—Rivastigmine—Alzheimer's disease	0.000313	0.00136	CcSEcCtD
Bisoprolol—Chlorphenesin—PTGS2—Alzheimer's disease	0.000313	0.102	CrCbGaD
Bisoprolol—Hallucination—Memantine—Alzheimer's disease	0.000313	0.00136	CcSEcCtD
Bisoprolol—Hypoaesthesia—Memantine—Alzheimer's disease	0.000313	0.00136	CcSEcCtD
Bisoprolol—Shock—Galantamine—Alzheimer's disease	0.000313	0.00136	CcSEcCtD
Bisoprolol—Alprenolol—CYP2D6—Alzheimer's disease	0.000312	0.102	CrCbGaD
Bisoprolol—Pharyngitis—Memantine—Alzheimer's disease	0.000312	0.00136	CcSEcCtD
Bisoprolol—Nervous system disorder—Galantamine—Alzheimer's disease	0.000312	0.00135	CcSEcCtD
Bisoprolol—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000311	0.00135	CcSEcCtD
Bisoprolol—Tachycardia—Galantamine—Alzheimer's disease	0.00031	0.00135	CcSEcCtD
Bisoprolol—Oedema peripheral—Memantine—Alzheimer's disease	0.00031	0.00134	CcSEcCtD
Bisoprolol—Arrhythmia—Donepezil—Alzheimer's disease	0.00031	0.00134	CcSEcCtD
Bisoprolol—Connective tissue disorder—Memantine—Alzheimer's disease	0.000309	0.00134	CcSEcCtD
Bisoprolol—Rhinitis—Rivastigmine—Alzheimer's disease	0.000309	0.00134	CcSEcCtD
Bisoprolol—Skin disorder—Galantamine—Alzheimer's disease	0.000309	0.00134	CcSEcCtD
Bisoprolol—Hepatitis—Rivastigmine—Alzheimer's disease	0.000308	0.00134	CcSEcCtD
Bisoprolol—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000307	0.00133	CcSEcCtD
Bisoprolol—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000306	0.00133	CcSEcCtD
Bisoprolol—Hallucination—Rivastigmine—Alzheimer's disease	0.000306	0.00133	CcSEcCtD
Bisoprolol—Alopecia—Donepezil—Alzheimer's disease	0.000306	0.00133	CcSEcCtD
Bisoprolol—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000305	0.00133	CcSEcCtD
Bisoprolol—Mental disorder—Donepezil—Alzheimer's disease	0.000304	0.00132	CcSEcCtD
Bisoprolol—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000303	0.00132	CcSEcCtD
Bisoprolol—Visual impairment—Memantine—Alzheimer's disease	0.000303	0.00132	CcSEcCtD
Bisoprolol—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000302	0.00131	CcSEcCtD
Bisoprolol—Erythema—Donepezil—Alzheimer's disease	0.000302	0.00131	CcSEcCtD
Bisoprolol—Hypotension—Galantamine—Alzheimer's disease	0.000297	0.00129	CcSEcCtD
Bisoprolol—Visual impairment—Rivastigmine—Alzheimer's disease	0.000297	0.00129	CcSEcCtD
Bisoprolol—Dysgeusia—Donepezil—Alzheimer's disease	0.000295	0.00128	CcSEcCtD
Bisoprolol—Eye disorder—Memantine—Alzheimer's disease	0.000294	0.00128	CcSEcCtD
Bisoprolol—Tinnitus—Memantine—Alzheimer's disease	0.000293	0.00127	CcSEcCtD
Bisoprolol—Flushing—Memantine—Alzheimer's disease	0.000292	0.00127	CcSEcCtD
Bisoprolol—Cardiac disorder—Memantine—Alzheimer's disease	0.000292	0.00127	CcSEcCtD
Bisoprolol—Back pain—Donepezil—Alzheimer's disease	0.000292	0.00127	CcSEcCtD
Bisoprolol—Metoprolol—CYP2D6—Alzheimer's disease	0.000291	0.0945	CrCbGaD
Bisoprolol—Muscle spasms—Donepezil—Alzheimer's disease	0.00029	0.00126	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000289	0.00126	CcSEcCtD
Bisoprolol—Eye disorder—Rivastigmine—Alzheimer's disease	0.000288	0.00125	CcSEcCtD
Bisoprolol—Insomnia—Galantamine—Alzheimer's disease	0.000287	0.00125	CcSEcCtD
Bisoprolol—Tinnitus—Rivastigmine—Alzheimer's disease	0.000287	0.00125	CcSEcCtD
Bisoprolol—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000286	0.00124	CcSEcCtD
Bisoprolol—Flushing—Rivastigmine—Alzheimer's disease	0.000286	0.00124	CcSEcCtD
Bisoprolol—Angiopathy—Memantine—Alzheimer's disease	0.000285	0.00124	CcSEcCtD
Bisoprolol—Paraesthesia—Galantamine—Alzheimer's disease	0.000285	0.00124	CcSEcCtD
Bisoprolol—Mediastinal disorder—Memantine—Alzheimer's disease	0.000284	0.00123	CcSEcCtD
Bisoprolol—Tremor—Donepezil—Alzheimer's disease	0.000283	0.00123	CcSEcCtD
Bisoprolol—Somnolence—Galantamine—Alzheimer's disease	0.000282	0.00123	CcSEcCtD
Bisoprolol—Arrhythmia—Memantine—Alzheimer's disease	0.000281	0.00122	CcSEcCtD
Bisoprolol—Ill-defined disorder—Donepezil—Alzheimer's disease	0.00028	0.00121	CcSEcCtD
Bisoprolol—Dyspepsia—Galantamine—Alzheimer's disease	0.00028	0.00121	CcSEcCtD
Bisoprolol—Angiopathy—Rivastigmine—Alzheimer's disease	0.000279	0.00121	CcSEcCtD
Bisoprolol—Alopecia—Memantine—Alzheimer's disease	0.000278	0.00121	CcSEcCtD
Bisoprolol—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000277	0.0012	CcSEcCtD
Bisoprolol—Agitation—Donepezil—Alzheimer's disease	0.000277	0.0012	CcSEcCtD
Bisoprolol—Mental disorder—Memantine—Alzheimer's disease	0.000276	0.0012	CcSEcCtD
Bisoprolol—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000275	0.00119	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000274	0.00119	CcSEcCtD
Bisoprolol—Fatigue—Galantamine—Alzheimer's disease	0.000274	0.00119	CcSEcCtD
Bisoprolol—Malaise—Donepezil—Alzheimer's disease	0.000272	0.00118	CcSEcCtD
Bisoprolol—Alopecia—Rivastigmine—Alzheimer's disease	0.000272	0.00118	CcSEcCtD
Bisoprolol—Constipation—Galantamine—Alzheimer's disease	0.000272	0.00118	CcSEcCtD
Bisoprolol—Vertigo—Donepezil—Alzheimer's disease	0.000271	0.00118	CcSEcCtD
Bisoprolol—Syncope—Donepezil—Alzheimer's disease	0.000271	0.00117	CcSEcCtD
Bisoprolol—Mental disorder—Rivastigmine—Alzheimer's disease	0.00027	0.00117	CcSEcCtD
Bisoprolol—Pindolol—CYP2D6—Alzheimer's disease	0.000269	0.0875	CrCbGaD
Bisoprolol—Dysgeusia—Memantine—Alzheimer's disease	0.000268	0.00116	CcSEcCtD
Bisoprolol—Erythema—Rivastigmine—Alzheimer's disease	0.000268	0.00116	CcSEcCtD
Bisoprolol—Loss of consciousness—Donepezil—Alzheimer's disease	0.000265	0.00115	CcSEcCtD
Bisoprolol—Back pain—Memantine—Alzheimer's disease	0.000265	0.00115	CcSEcCtD
Bisoprolol—Cough—Donepezil—Alzheimer's disease	0.000263	0.00114	CcSEcCtD
Bisoprolol—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000262	0.00114	CcSEcCtD
Bisoprolol—Feeling abnormal—Galantamine—Alzheimer's disease	0.000262	0.00114	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00026	0.00113	CcSEcCtD
Bisoprolol—Back pain—Rivastigmine—Alzheimer's disease	0.000259	0.00112	CcSEcCtD
Bisoprolol—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000258	0.00112	CcSEcCtD
Bisoprolol—Arthralgia—Donepezil—Alzheimer's disease	0.000257	0.00111	CcSEcCtD
Bisoprolol—Chest pain—Donepezil—Alzheimer's disease	0.000257	0.00111	CcSEcCtD
Bisoprolol—Myalgia—Donepezil—Alzheimer's disease	0.000257	0.00111	CcSEcCtD
Bisoprolol—Tremor—Memantine—Alzheimer's disease	0.000257	0.00111	CcSEcCtD
Bisoprolol—Anxiety—Donepezil—Alzheimer's disease	0.000256	0.00111	CcSEcCtD
Bisoprolol—Ill-defined disorder—Memantine—Alzheimer's disease	0.000254	0.0011	CcSEcCtD
Bisoprolol—Discomfort—Donepezil—Alzheimer's disease	0.000254	0.0011	CcSEcCtD
Bisoprolol—Agitation—Memantine—Alzheimer's disease	0.000252	0.00109	CcSEcCtD
Bisoprolol—Dry mouth—Donepezil—Alzheimer's disease	0.000251	0.00109	CcSEcCtD
Bisoprolol—Body temperature increased—Galantamine—Alzheimer's disease	0.000251	0.00109	CcSEcCtD
Bisoprolol—Abdominal pain—Galantamine—Alzheimer's disease	0.000251	0.00109	CcSEcCtD
Bisoprolol—Tremor—Rivastigmine—Alzheimer's disease	0.000251	0.00109	CcSEcCtD
Bisoprolol—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000249	0.00108	CcSEcCtD
Bisoprolol—Confusional state—Donepezil—Alzheimer's disease	0.000248	0.00108	CcSEcCtD
Bisoprolol—Malaise—Memantine—Alzheimer's disease	0.000247	0.00107	CcSEcCtD
Bisoprolol—Agitation—Rivastigmine—Alzheimer's disease	0.000246	0.00107	CcSEcCtD
Bisoprolol—Oedema—Donepezil—Alzheimer's disease	0.000246	0.00107	CcSEcCtD
Bisoprolol—Vertigo—Memantine—Alzheimer's disease	0.000246	0.00107	CcSEcCtD
Bisoprolol—Syncope—Memantine—Alzheimer's disease	0.000246	0.00107	CcSEcCtD
Bisoprolol—Infection—Donepezil—Alzheimer's disease	0.000245	0.00106	CcSEcCtD
Bisoprolol—Shock—Donepezil—Alzheimer's disease	0.000242	0.00105	CcSEcCtD
Bisoprolol—Palpitations—Memantine—Alzheimer's disease	0.000242	0.00105	CcSEcCtD
Bisoprolol—Malaise—Rivastigmine—Alzheimer's disease	0.000242	0.00105	CcSEcCtD
Bisoprolol—Nervous system disorder—Donepezil—Alzheimer's disease	0.000241	0.00105	CcSEcCtD
Bisoprolol—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000241	0.00105	CcSEcCtD
Bisoprolol—Vertigo—Rivastigmine—Alzheimer's disease	0.000241	0.00104	CcSEcCtD
Bisoprolol—Loss of consciousness—Memantine—Alzheimer's disease	0.000241	0.00104	CcSEcCtD
Bisoprolol—Syncope—Rivastigmine—Alzheimer's disease	0.00024	0.00104	CcSEcCtD
Bisoprolol—Cough—Memantine—Alzheimer's disease	0.000239	0.00104	CcSEcCtD
Bisoprolol—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000238	0.00103	CcSEcCtD
Bisoprolol—Palpitations—Rivastigmine—Alzheimer's disease	0.000237	0.00103	CcSEcCtD
Bisoprolol—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000236	0.00102	CcSEcCtD
Bisoprolol—Hypersensitivity—Galantamine—Alzheimer's disease	0.000234	0.00102	CcSEcCtD
Bisoprolol—Cough—Rivastigmine—Alzheimer's disease	0.000234	0.00101	CcSEcCtD
Bisoprolol—Chest pain—Memantine—Alzheimer's disease	0.000233	0.00101	CcSEcCtD
Bisoprolol—Arthralgia—Memantine—Alzheimer's disease	0.000233	0.00101	CcSEcCtD
Bisoprolol—Myalgia—Memantine—Alzheimer's disease	0.000233	0.00101	CcSEcCtD
Bisoprolol—Anxiety—Memantine—Alzheimer's disease	0.000232	0.00101	CcSEcCtD
Bisoprolol—Discomfort—Memantine—Alzheimer's disease	0.00023	0.001	CcSEcCtD
Bisoprolol—Hypotension—Donepezil—Alzheimer's disease	0.00023	0.000998	CcSEcCtD
Bisoprolol—Myalgia—Rivastigmine—Alzheimer's disease	0.000228	0.00099	CcSEcCtD
Bisoprolol—Chest pain—Rivastigmine—Alzheimer's disease	0.000228	0.00099	CcSEcCtD
Bisoprolol—Arthralgia—Rivastigmine—Alzheimer's disease	0.000228	0.00099	CcSEcCtD
Bisoprolol—Dry mouth—Memantine—Alzheimer's disease	0.000228	0.00099	CcSEcCtD
Bisoprolol—Asthenia—Galantamine—Alzheimer's disease	0.000228	0.000989	CcSEcCtD
Bisoprolol—Anxiety—Rivastigmine—Alzheimer's disease	0.000227	0.000986	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000227	0.000983	CcSEcCtD
Bisoprolol—Confusional state—Memantine—Alzheimer's disease	0.000225	0.000978	CcSEcCtD
Bisoprolol—Discomfort—Rivastigmine—Alzheimer's disease	0.000225	0.000978	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000224	0.000973	CcSEcCtD
Bisoprolol—Oedema—Memantine—Alzheimer's disease	0.000224	0.00097	CcSEcCtD
Bisoprolol—Dry mouth—Rivastigmine—Alzheimer's disease	0.000223	0.000968	CcSEcCtD
Bisoprolol—Insomnia—Donepezil—Alzheimer's disease	0.000223	0.000966	CcSEcCtD
Bisoprolol—Infection—Memantine—Alzheimer's disease	0.000222	0.000964	CcSEcCtD
Bisoprolol—Paraesthesia—Donepezil—Alzheimer's disease	0.000221	0.000959	CcSEcCtD
Bisoprolol—Confusional state—Rivastigmine—Alzheimer's disease	0.00022	0.000957	CcSEcCtD
Bisoprolol—Shock—Memantine—Alzheimer's disease	0.00022	0.000954	CcSEcCtD
Bisoprolol—Dyspnoea—Donepezil—Alzheimer's disease	0.000219	0.000952	CcSEcCtD
Bisoprolol—Nervous system disorder—Memantine—Alzheimer's disease	0.000219	0.000951	CcSEcCtD
Bisoprolol—Somnolence—Donepezil—Alzheimer's disease	0.000219	0.00095	CcSEcCtD
Bisoprolol—Thrombocytopenia—Memantine—Alzheimer's disease	0.000219	0.00095	CcSEcCtD
Bisoprolol—Oedema—Rivastigmine—Alzheimer's disease	0.000219	0.000949	CcSEcCtD
Bisoprolol—Tachycardia—Memantine—Alzheimer's disease	0.000218	0.000947	CcSEcCtD
Bisoprolol—Diarrhoea—Galantamine—Alzheimer's disease	0.000217	0.000943	CcSEcCtD
Bisoprolol—Infection—Rivastigmine—Alzheimer's disease	0.000217	0.000943	CcSEcCtD
Bisoprolol—Skin disorder—Memantine—Alzheimer's disease	0.000217	0.000942	CcSEcCtD
Bisoprolol—Dyspepsia—Donepezil—Alzheimer's disease	0.000217	0.00094	CcSEcCtD
Bisoprolol—Hyperhidrosis—Memantine—Alzheimer's disease	0.000216	0.000938	CcSEcCtD
Bisoprolol—Shock—Rivastigmine—Alzheimer's disease	0.000215	0.000934	CcSEcCtD
Bisoprolol—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000214	0.000931	CcSEcCtD
Bisoprolol—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000214	0.000929	CcSEcCtD
Bisoprolol—Tachycardia—Rivastigmine—Alzheimer's disease	0.000213	0.000926	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000213	0.000922	CcSEcCtD
Bisoprolol—Skin disorder—Rivastigmine—Alzheimer's disease	0.000212	0.000922	CcSEcCtD
Bisoprolol—Fatigue—Donepezil—Alzheimer's disease	0.000212	0.000921	CcSEcCtD
Bisoprolol—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000211	0.000917	CcSEcCtD
Bisoprolol—Constipation—Donepezil—Alzheimer's disease	0.000211	0.000914	CcSEcCtD
Bisoprolol—Pain—Donepezil—Alzheimer's disease	0.000211	0.000914	CcSEcCtD
Bisoprolol—Dizziness—Galantamine—Alzheimer's disease	0.00021	0.000912	CcSEcCtD
Bisoprolol—Hypotension—Memantine—Alzheimer's disease	0.000209	0.000906	CcSEcCtD
Bisoprolol—Hypotension—Rivastigmine—Alzheimer's disease	0.000204	0.000887	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000204	0.000884	CcSEcCtD
Bisoprolol—Feeling abnormal—Donepezil—Alzheimer's disease	0.000203	0.00088	CcSEcCtD
Bisoprolol—Insomnia—Memantine—Alzheimer's disease	0.000202	0.000877	CcSEcCtD
Bisoprolol—Vomiting—Galantamine—Alzheimer's disease	0.000202	0.000876	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000201	0.000874	CcSEcCtD
Bisoprolol—Paraesthesia—Memantine—Alzheimer's disease	0.000201	0.000871	CcSEcCtD
Bisoprolol—Rash—Galantamine—Alzheimer's disease	0.0002	0.000869	CcSEcCtD
Bisoprolol—Dermatitis—Galantamine—Alzheimer's disease	0.0002	0.000868	CcSEcCtD
Bisoprolol—Dyspnoea—Memantine—Alzheimer's disease	0.000199	0.000865	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000199	0.000865	CcSEcCtD
Bisoprolol—Headache—Galantamine—Alzheimer's disease	0.000199	0.000864	CcSEcCtD
Bisoprolol—Somnolence—Memantine—Alzheimer's disease	0.000199	0.000862	CcSEcCtD
Bisoprolol—Insomnia—Rivastigmine—Alzheimer's disease	0.000198	0.000858	CcSEcCtD
Bisoprolol—Dyspepsia—Memantine—Alzheimer's disease	0.000197	0.000854	CcSEcCtD
Bisoprolol—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000196	0.000852	CcSEcCtD
Bisoprolol—Urticaria—Donepezil—Alzheimer's disease	0.000196	0.000849	CcSEcCtD
Bisoprolol—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000195	0.000846	CcSEcCtD
Bisoprolol—Abdominal pain—Donepezil—Alzheimer's disease	0.000195	0.000845	CcSEcCtD
Bisoprolol—Body temperature increased—Donepezil—Alzheimer's disease	0.000195	0.000845	CcSEcCtD
Bisoprolol—Somnolence—Rivastigmine—Alzheimer's disease	0.000194	0.000844	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000193	0.000837	CcSEcCtD
Bisoprolol—Fatigue—Memantine—Alzheimer's disease	0.000193	0.000836	CcSEcCtD
Bisoprolol—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000192	0.000835	CcSEcCtD
Bisoprolol—Pain—Memantine—Alzheimer's disease	0.000191	0.000829	CcSEcCtD
Bisoprolol—Constipation—Memantine—Alzheimer's disease	0.000191	0.000829	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000189	0.000819	CcSEcCtD
Bisoprolol—Nausea—Galantamine—Alzheimer's disease	0.000189	0.000819	CcSEcCtD
Bisoprolol—Fatigue—Rivastigmine—Alzheimer's disease	0.000189	0.000818	CcSEcCtD
Bisoprolol—Pain—Rivastigmine—Alzheimer's disease	0.000187	0.000811	CcSEcCtD
Bisoprolol—Constipation—Rivastigmine—Alzheimer's disease	0.000187	0.000811	CcSEcCtD
Bisoprolol—Feeling abnormal—Memantine—Alzheimer's disease	0.000184	0.000799	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000183	0.000793	CcSEcCtD
Bisoprolol—Hypersensitivity—Donepezil—Alzheimer's disease	0.000181	0.000787	CcSEcCtD
Bisoprolol—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.00018	0.000782	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000179	0.000776	CcSEcCtD
Bisoprolol—Urticaria—Memantine—Alzheimer's disease	0.000178	0.000771	CcSEcCtD
Bisoprolol—Abdominal pain—Memantine—Alzheimer's disease	0.000177	0.000767	CcSEcCtD
Bisoprolol—Body temperature increased—Memantine—Alzheimer's disease	0.000177	0.000767	CcSEcCtD
Bisoprolol—Asthenia—Donepezil—Alzheimer's disease	0.000177	0.000766	CcSEcCtD
Bisoprolol—Pruritus—Donepezil—Alzheimer's disease	0.000174	0.000756	CcSEcCtD
Bisoprolol—Urticaria—Rivastigmine—Alzheimer's disease	0.000174	0.000754	CcSEcCtD
Bisoprolol—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000173	0.00075	CcSEcCtD
Bisoprolol—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000173	0.00075	CcSEcCtD
Bisoprolol—Diarrhoea—Donepezil—Alzheimer's disease	0.000168	0.000731	CcSEcCtD
Bisoprolol—Hypersensitivity—Memantine—Alzheimer's disease	0.000165	0.000715	CcSEcCtD
Bisoprolol—Dizziness—Donepezil—Alzheimer's disease	0.000163	0.000706	CcSEcCtD
Bisoprolol—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000161	0.000699	CcSEcCtD
Bisoprolol—Asthenia—Memantine—Alzheimer's disease	0.00016	0.000696	CcSEcCtD
Bisoprolol—Pruritus—Memantine—Alzheimer's disease	0.000158	0.000686	CcSEcCtD
Bisoprolol—Asthenia—Rivastigmine—Alzheimer's disease	0.000157	0.000681	CcSEcCtD
Bisoprolol—Vomiting—Donepezil—Alzheimer's disease	0.000157	0.000679	CcSEcCtD
Bisoprolol—Rash—Donepezil—Alzheimer's disease	0.000155	0.000674	CcSEcCtD
Bisoprolol—Dermatitis—Donepezil—Alzheimer's disease	0.000155	0.000673	CcSEcCtD
Bisoprolol—Pruritus—Rivastigmine—Alzheimer's disease	0.000155	0.000671	CcSEcCtD
Bisoprolol—Headache—Donepezil—Alzheimer's disease	0.000154	0.000669	CcSEcCtD
Bisoprolol—Diarrhoea—Memantine—Alzheimer's disease	0.000153	0.000664	CcSEcCtD
Bisoprolol—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00015	0.000649	CcSEcCtD
Bisoprolol—Dizziness—Memantine—Alzheimer's disease	0.000148	0.000641	CcSEcCtD
Bisoprolol—Propranolol—CYP2D6—Alzheimer's disease	0.000147	0.0477	CrCbGaD
Bisoprolol—Nausea—Donepezil—Alzheimer's disease	0.000146	0.000635	CcSEcCtD
Bisoprolol—Dizziness—Rivastigmine—Alzheimer's disease	0.000145	0.000627	CcSEcCtD
Bisoprolol—Vomiting—Memantine—Alzheimer's disease	0.000142	0.000617	CcSEcCtD
Bisoprolol—Rash—Memantine—Alzheimer's disease	0.000141	0.000612	CcSEcCtD
Bisoprolol—Dermatitis—Memantine—Alzheimer's disease	0.000141	0.000611	CcSEcCtD
Bisoprolol—Headache—Memantine—Alzheimer's disease	0.00014	0.000608	CcSEcCtD
Bisoprolol—Vomiting—Rivastigmine—Alzheimer's disease	0.000139	0.000603	CcSEcCtD
Bisoprolol—Rash—Rivastigmine—Alzheimer's disease	0.000138	0.000598	CcSEcCtD
Bisoprolol—Dermatitis—Rivastigmine—Alzheimer's disease	0.000138	0.000598	CcSEcCtD
Bisoprolol—Headache—Rivastigmine—Alzheimer's disease	0.000137	0.000594	CcSEcCtD
Bisoprolol—Nausea—Memantine—Alzheimer's disease	0.000133	0.000576	CcSEcCtD
Bisoprolol—Nausea—Rivastigmine—Alzheimer's disease	0.00013	0.000564	CcSEcCtD
Bisoprolol—ADRB2—Signaling Pathways—TTR—Alzheimer's disease	2.49e-05	0.00144	CbGpPWpGaD
Bisoprolol—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	2.48e-05	0.00144	CbGpPWpGaD
Bisoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	2.47e-05	0.00143	CbGpPWpGaD
Bisoprolol—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	2.43e-05	0.00141	CbGpPWpGaD
Bisoprolol—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	2.4e-05	0.00139	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—NPY—Alzheimer's disease	2.25e-05	0.00131	CbGpPWpGaD
Bisoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	2.25e-05	0.00131	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR ligand binding—CCR5—Alzheimer's disease	2.24e-05	0.0013	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—IAPP—Alzheimer's disease	2.24e-05	0.0013	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PYY—Alzheimer's disease	2.22e-05	0.00129	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—NPY—Alzheimer's disease	2.2e-05	0.00128	CbGpPWpGaD
Bisoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	2.2e-05	0.00128	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR ligand binding—HTR2A—Alzheimer's disease	2.19e-05	0.00127	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR ligand binding—CCR5—Alzheimer's disease	2.19e-05	0.00127	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—IAPP—Alzheimer's disease	2.19e-05	0.00127	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—CRH—Alzheimer's disease	2.17e-05	0.00126	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PYY—Alzheimer's disease	2.17e-05	0.00126	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—DHCR24—Alzheimer's disease	2.15e-05	0.00124	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR ligand binding—HTR2A—Alzheimer's disease	2.15e-05	0.00124	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—CRH—Alzheimer's disease	2.13e-05	0.00123	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—NPS—Alzheimer's disease	2.06e-05	0.00119	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—NPY—Alzheimer's disease	2.05e-05	0.00119	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—IAPP—Alzheimer's disease	2.03e-05	0.00118	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—NPS—Alzheimer's disease	2.02e-05	0.00117	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—NPY—Alzheimer's disease	2e-05	0.00116	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—IAPP—Alzheimer's disease	1.99e-05	0.00115	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—CRH—Alzheimer's disease	1.97e-05	0.00114	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—GAB2—Alzheimer's disease	1.97e-05	0.00114	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—SST—Alzheimer's disease	1.97e-05	0.00114	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—CRH—Alzheimer's disease	1.93e-05	0.00112	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CDK5—Alzheimer's disease	1.93e-05	0.00112	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR ligand binding—F2—Alzheimer's disease	1.92e-05	0.00112	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—SST—Alzheimer's disease	1.92e-05	0.00112	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—GAB2—Alzheimer's disease	1.92e-05	0.00112	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—APP—Alzheimer's disease	1.92e-05	0.00111	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CDK5—Alzheimer's disease	1.88e-05	0.00109	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR ligand binding—F2—Alzheimer's disease	1.88e-05	0.00109	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—APP—Alzheimer's disease	1.87e-05	0.00109	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—NPS—Alzheimer's disease	1.87e-05	0.00109	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—PPP3CA—Alzheimer's disease	1.86e-05	0.00108	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—HTR6—Alzheimer's disease	1.85e-05	0.00107	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—NPS—Alzheimer's disease	1.83e-05	0.00106	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CA4—Alzheimer's disease	1.83e-05	0.00106	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—PPP3CA—Alzheimer's disease	1.82e-05	0.00106	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—HTR6—Alzheimer's disease	1.81e-05	0.00105	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—PLCB1—Alzheimer's disease	1.81e-05	0.00105	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—SST—Alzheimer's disease	1.79e-05	0.00104	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—GAB2—Alzheimer's disease	1.79e-05	0.00104	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—PLCB1—Alzheimer's disease	1.77e-05	0.00103	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—SST—Alzheimer's disease	1.75e-05	0.00101	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—GAB2—Alzheimer's disease	1.75e-05	0.00101	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—APP—Alzheimer's disease	1.74e-05	0.00101	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—GAPDHS—Alzheimer's disease	1.72e-05	0.000995	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR ligand binding—CCL2—Alzheimer's disease	1.71e-05	0.000994	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—APP—Alzheimer's disease	1.7e-05	0.000987	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PSENEN—Alzheimer's disease	1.68e-05	0.000975	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR ligand binding—CCL2—Alzheimer's disease	1.68e-05	0.000972	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—APH1A—Alzheimer's disease	1.66e-05	0.000962	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PSENEN—Alzheimer's disease	1.65e-05	0.000954	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—PLCB1—Alzheimer's disease	1.64e-05	0.000952	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ATP5A1—Alzheimer's disease	1.63e-05	0.000943	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—APH1A—Alzheimer's disease	1.62e-05	0.000941	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—NCSTN—Alzheimer's disease	1.62e-05	0.000937	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—PLCB1—Alzheimer's disease	1.61e-05	0.000931	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—NCSTN—Alzheimer's disease	1.58e-05	0.000916	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—LRP1—Alzheimer's disease	1.58e-05	0.000913	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PLD3—Alzheimer's disease	1.55e-05	0.0009	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—LRP1—Alzheimer's disease	1.54e-05	0.000893	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—GFAP—Alzheimer's disease	1.54e-05	0.000892	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—GAL—Alzheimer's disease	1.54e-05	0.000892	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—GAL—Alzheimer's disease	1.51e-05	0.000873	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—GFAP—Alzheimer's disease	1.51e-05	0.000873	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—HSD17B10—Alzheimer's disease	1.49e-05	0.000863	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CYP46A1—Alzheimer's disease	1.43e-05	0.00083	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	1.4e-05	0.000814	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ND1—Alzheimer's disease	1.38e-05	0.000802	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—A2M—Alzheimer's disease	1.36e-05	0.000786	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.34e-05	0.000775	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—A2M—Alzheimer's disease	1.33e-05	0.000769	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PSEN2—Alzheimer's disease	1.31e-05	0.000761	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.31e-05	0.000758	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PSEN2—Alzheimer's disease	1.29e-05	0.000745	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—CCR5—Alzheimer's disease	1.27e-05	0.000734	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.24e-05	0.000719	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—CCR5—Alzheimer's disease	1.24e-05	0.000718	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—PRKCG—Alzheimer's disease	1.21e-05	0.000704	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.21e-05	0.000703	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—NPY—Alzheimer's disease	1.21e-05	0.000701	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—IAPP—Alzheimer's disease	1.2e-05	0.000696	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CA4—Alzheimer's disease	1.19e-05	0.000692	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—PRKCG—Alzheimer's disease	1.19e-05	0.000689	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—NPY—Alzheimer's disease	1.18e-05	0.000686	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—IAPP—Alzheimer's disease	1.18e-05	0.000681	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CRH—Alzheimer's disease	1.17e-05	0.000676	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—CCR5—Alzheimer's disease	1.15e-05	0.000667	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CRH—Alzheimer's disease	1.14e-05	0.000661	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—HTR2A—Alzheimer's disease	1.13e-05	0.000653	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—CCR5—Alzheimer's disease	1.13e-05	0.000652	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	1.12e-05	0.000651	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—NPS—Alzheimer's disease	1.11e-05	0.000641	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—HTR2A—Alzheimer's disease	1.1e-05	0.000639	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PPP3CA—Alzheimer's disease	1.1e-05	0.000638	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—F2—Alzheimer's disease	1.09e-05	0.00063	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PTK2B—Alzheimer's disease	1.08e-05	0.000629	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—NPS—Alzheimer's disease	1.08e-05	0.000627	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PPP3CA—Alzheimer's disease	1.08e-05	0.000624	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	1.06e-05	0.000617	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—F2—Alzheimer's disease	1.06e-05	0.000616	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PTK2B—Alzheimer's disease	1.06e-05	0.000615	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—SST—Alzheimer's disease	1.05e-05	0.000611	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—GAB2—Alzheimer's disease	1.05e-05	0.000611	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—NTRK2—Alzheimer's disease	1.05e-05	0.000611	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—CALM1—Alzheimer's disease	1.05e-05	0.000609	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—GSK3A—Alzheimer's disease	1.05e-05	0.000606	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—SST—Alzheimer's disease	1.03e-05	0.000598	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—GAB2—Alzheimer's disease	1.03e-05	0.000598	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—NTRK2—Alzheimer's disease	1.03e-05	0.000598	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—APP—Alzheimer's disease	1.03e-05	0.000596	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—CALM1—Alzheimer's disease	1.03e-05	0.000596	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—GSK3A—Alzheimer's disease	1.02e-05	0.000593	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PLD3—Alzheimer's disease	1.02e-05	0.000588	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—APP—Alzheimer's disease	1.01e-05	0.000583	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—F2—Alzheimer's disease	9.87e-06	0.000572	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	9.73e-06	0.000564	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PLCB1—Alzheimer's disease	9.7e-06	0.000562	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—F2—Alzheimer's disease	9.66e-06	0.00056	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PLCB1—Alzheimer's disease	9.49e-06	0.00055	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	9.37e-06	0.000543	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—NGFR—Alzheimer's disease	9.05e-06	0.000525	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ND1—Alzheimer's disease	9.05e-06	0.000524	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—CREB1—Alzheimer's disease	8.99e-06	0.000521	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CHAT—Alzheimer's disease	8.92e-06	0.000517	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—TPI1—Alzheimer's disease	8.92e-06	0.000517	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—NGFR—Alzheimer's disease	8.85e-06	0.000513	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—ADAM10—Alzheimer's disease	8.84e-06	0.000512	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—CCL2—Alzheimer's disease	8.8e-06	0.00051	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—CREB1—Alzheimer's disease	8.8e-06	0.00051	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—ADAM10—Alzheimer's disease	8.65e-06	0.000501	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—CCL2—Alzheimer's disease	8.61e-06	0.000499	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—MAOB—Alzheimer's disease	8.55e-06	0.000495	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—S100B—Alzheimer's disease	8.36e-06	0.000485	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	8.23e-06	0.000477	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—S100B—Alzheimer's disease	8.18e-06	0.000474	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—IGF2—Alzheimer's disease	7.96e-06	0.000461	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—A2M—Alzheimer's disease	7.95e-06	0.000461	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—IGF2—Alzheimer's disease	7.79e-06	0.000451	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—IGF1R—Alzheimer's disease	7.7e-06	0.000446	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—IGF1R—Alzheimer's disease	7.53e-06	0.000436	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—LPL—Alzheimer's disease	7.38e-06	0.000428	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—MEF2C—Alzheimer's disease	7.31e-06	0.000424	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—LPL—Alzheimer's disease	7.22e-06	0.000418	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PRKCG—Alzheimer's disease	7.17e-06	0.000416	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—MEF2C—Alzheimer's disease	7.15e-06	0.000415	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PRKCG—Alzheimer's disease	7.02e-06	0.000407	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—NGF—Alzheimer's disease	6.99e-06	0.000405	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ACHE—Alzheimer's disease	6.91e-06	0.000401	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—NGF—Alzheimer's disease	6.84e-06	0.000396	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	6.83e-06	0.000396	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CCR5—Alzheimer's disease	6.8e-06	0.000394	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—HTR2A—Alzheimer's disease	6.65e-06	0.000386	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CCR5—Alzheimer's disease	6.65e-06	0.000385	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—HTR2A—Alzheimer's disease	6.51e-06	0.000377	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ENO1—Alzheimer's disease	6.48e-06	0.000376	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	6.48e-06	0.000376	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CALM1—Alzheimer's disease	6.21e-06	0.00036	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—APOE—Alzheimer's disease	6.18e-06	0.000358	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—LEP—Alzheimer's disease	6.18e-06	0.000358	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CAV1—Alzheimer's disease	6.13e-06	0.000355	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CALM1—Alzheimer's disease	6.07e-06	0.000352	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—LEP—Alzheimer's disease	6.05e-06	0.000351	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—APOE—Alzheimer's disease	6.05e-06	0.000351	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—BCHE—Alzheimer's disease	6.02e-06	0.000349	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CAV1—Alzheimer's disease	5.99e-06	0.000347	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—ESR1—Alzheimer's disease	5.9e-06	0.000342	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—F2—Alzheimer's disease	5.83e-06	0.000338	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CHAT—Alzheimer's disease	5.83e-06	0.000338	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—TPI1—Alzheimer's disease	5.83e-06	0.000338	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—ESR1—Alzheimer's disease	5.78e-06	0.000335	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—NOTCH1—Alzheimer's disease	5.71e-06	0.000331	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—F2—Alzheimer's disease	5.71e-06	0.000331	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	5.68e-06	0.000329	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—MAOB—Alzheimer's disease	5.59e-06	0.000324	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—NOTCH1—Alzheimer's disease	5.58e-06	0.000324	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	5.51e-06	0.000319	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	5.38e-06	0.000312	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—GSK3B—Alzheimer's disease	5.36e-06	0.00031	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CREB1—Alzheimer's disease	5.31e-06	0.000308	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—INS—Alzheimer's disease	5.28e-06	0.000306	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—GSK3B—Alzheimer's disease	5.24e-06	0.000304	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CCL2—Alzheimer's disease	5.2e-06	0.000301	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CREB1—Alzheimer's disease	5.2e-06	0.000301	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—A2M—Alzheimer's disease	5.2e-06	0.000301	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—INS—Alzheimer's disease	5.17e-06	0.0003	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—IGF1—Alzheimer's disease	5.11e-06	0.000296	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CCL2—Alzheimer's disease	5.09e-06	0.000295	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—IGF1—Alzheimer's disease	5e-06	0.00029	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	4.75e-06	0.000275	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	4.73e-06	0.000274	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—NOS3—Alzheimer's disease	4.63e-06	0.000269	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—NOS3—Alzheimer's disease	4.53e-06	0.000263	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ACHE—Alzheimer's disease	4.52e-06	0.000262	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	4.47e-06	0.000259	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—LPL—Alzheimer's disease	4.32e-06	0.000251	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ENO1—Alzheimer's disease	4.24e-06	0.000246	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	4.24e-06	0.000246	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	4.15e-06	0.000241	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—AKT1—Alzheimer's disease	3.97e-06	0.00023	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—BCHE—Alzheimer's disease	3.94e-06	0.000228	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CASP3—Alzheimer's disease	3.93e-06	0.000228	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—IL6—Alzheimer's disease	3.91e-06	0.000227	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	3.89e-06	0.000226	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—AKT1—Alzheimer's disease	3.88e-06	0.000225	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CASP3—Alzheimer's disease	3.85e-06	0.000223	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—IL6—Alzheimer's disease	3.82e-06	0.000222	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	3.72e-06	0.000215	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CALM1—Alzheimer's disease	3.64e-06	0.000211	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—APOE—Alzheimer's disease	3.62e-06	0.00021	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—MAPK8—Alzheimer's disease	3.62e-06	0.00021	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—AKT1—Alzheimer's disease	3.61e-06	0.000209	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	3.6e-06	0.000209	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CAV1—Alzheimer's disease	3.59e-06	0.000208	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—MAPK8—Alzheimer's disease	3.54e-06	0.000205	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—AKT1—Alzheimer's disease	3.53e-06	0.000204	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—VEGFA—Alzheimer's disease	3.34e-06	0.000193	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—VEGFA—Alzheimer's disease	3.27e-06	0.000189	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PPARG—Alzheimer's disease	3.16e-06	0.000183	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	3.1e-06	0.00018	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—INS—Alzheimer's disease	3.1e-06	0.000179	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	3.09e-06	0.000179	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—TGFB1—Alzheimer's disease	3.06e-06	0.000178	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—TGFB1—Alzheimer's disease	3e-06	0.000174	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—LPL—Alzheimer's disease	2.83e-06	0.000164	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—NOS3—Alzheimer's disease	2.71e-06	0.000157	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	2.54e-06	0.000147	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—TP53—Alzheimer's disease	2.52e-06	0.000146	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	2.48e-06	0.000144	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—TP53—Alzheimer's disease	2.47e-06	0.000143	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CALM1—Alzheimer's disease	2.38e-06	0.000138	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—APOE—Alzheimer's disease	2.37e-06	0.000137	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CAV1—Alzheimer's disease	2.35e-06	0.000136	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—IL6—Alzheimer's disease	2.31e-06	0.000134	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—IL6—Alzheimer's disease	2.26e-06	0.000131	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—AKT1—Alzheimer's disease	2.13e-06	0.000123	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—AKT1—Alzheimer's disease	2.08e-06	0.000121	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PPARG—Alzheimer's disease	2.06e-06	0.00012	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—INS—Alzheimer's disease	2.02e-06	0.000117	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.77e-06	0.000103	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.62e-06	9.41e-05	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.25e-06	7.23e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—AKT1—Alzheimer's disease	8.16e-07	4.73e-05	CbGpPWpGaD
